Aptevo Therapeutics (APVO) Times Interest Earned (2015 - 2026)
Aptevo Therapeutics (APVO) posted Times Interest Earned of -$19.88 for Q1 2026, down 61.09% sequentially from -$12.34 in Q4 2025, and down 5.51% YoY from -$21.03 in Q1 2025.
Aptevo Therapeutics (APVO) Times Interest Earned (2015 - 2026) Analysis & Trends
Aptevo Therapeutics has reported Times Interest Earned for 12 years, with the latest figure at -$19.88 in Q1 2026.
- Quarterly Times Interest Earned fell 5.51% year-over-year to -$19.88 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$77.53 (down 10.66% YoY) and the FY2025 annual result came in at -$4.41, down 31.63% from the prior year.
- Times Interest Earned fell to -$19.88 in Q1 2026 per APVO's latest filing, from -$12.34 in the prior quarter.
- Over five years, Times Interest Earned peaked at -$4.64 in Q4 2024 and troughed at -$67.44 in Q1 2023.
- A 5-year average of -$15.0 and a median of -$9.99 in 2022 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2022 and 2024: Times Interest Earned tumbled 994.69% in 2022, then jumped 69.9% in 2024.
- Over 5 years, Times Interest Earned stood at -$8.59 in 2022, then surged by 35.17% to -$5.57 in 2023, then grew by 16.67% to -$4.64 in 2024, then tumbled by 166.0% to -$12.34 in 2025, then plunged by 61.09% to -$19.88 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$19.88, -$12.34, and -$7.37 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Aptevo Therapeutics | 3.18 Mn | -6.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9.36 |
| Mar 31, 2026 | -19.88 |
| Dec 31, 2025 | -12.34 |
| Sep 30, 2025 | -7.37 |
| Jun 30, 2025 | -9.05 |
| Mar 31, 2025 | -18.84 |
| Dec 31, 2024 | -4.64 |
| Sep 30, 2024 | -5.05 |
| Jun 30, 2024 | -8.76 |
| Mar 31, 2024 | -20.30 |
| Dec 31, 2023 | -5.57 |
| Sep 30, 2023 | -8.17 |
| Jun 30, 2023 | -17.82 |
| Mar 31, 2023 | -67.44 |
| Dec 31, 2022 | -8.59 |
| Sep 30, 2022 | -9.99 |
| Jun 30, 2022 | -13.82 |
| Mar 31, 2022 | -17.37 |
| Sep 30, 2021 | -3.78 |
| Jun 30, 2021 | -2.09 |